Breadcrumb

[A05-19B] Ginkgo compounds in Alzheimer's disease

Overview

Overview

Commission: Commission awarded on 2005-02-22 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Executive summary of the final report  [PDF, 49 kB]Further documents
Contact address:to the contact form

Report documents

Report documents

PublishedDocumentSizeType 
2008-11-21 Executive summary of the final report 49 kBPDFdownload file
2008-11-21 Final report (German version) 2 MBPDFdownload file
2008-11-21 Documentation and appraisal of comments on the preliminary report version 2.0 (German version) 766 kBPDFdownload file
2008-02-29 Preliminary report version 2.0 (German version) 2 MBPDFdownload file
2007-10-09 Report plan version 2.0 (German version) 249 kBPDFdownload file
2007-10-09 Documentation and appraisal of comments on the report plan version 1.0 (German version) 5 MBPDFdownload file
2007-01-03 Preliminary report version 1.0 (German version) 585 kBPDFdownload file
2006-06-20 Amendment 1 to the report plan version 1.0 (German version) 37 kBPDFdownload file
2005-09-05 Report plan version 1.0 (German version) 88 kBPDFdownload file


At a glance

Accompanying information

Executive summary of the final report

  File-Icon  Ginkgo compounds in Alzheimer's disease [PDF, 49 kB]

Health information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealthonline.org.

Can Ginkgo products help?

Press releases

2009-09-10 Alzheimer’s disease: only a few therapies provide proof of benefit to patients

2008-11-21 Ginkgo biloba in Alzheimer's disease: evidence from studies is mixed



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close